Tumor Necrosis Factor Receptor 2 (TNFR2) expression is increasingly being linked to tolerogenic immune reactions and cells with suppressor function including a subset of T-regulatory cells. B-regulatory cells play an important role in control of T-cell responses and inflammation. Recently, we described TNFR2 as a marker for IL-10-producing B cells, a hallmark of this cell subset. Here, we demonstrate that proliferation of T cells is reduced in the presence of TNFR2 positive human memory B cells generated with TLR9 ligand, while TNFR2- and TNFR2+CD27- B cells display costimulatory activity. Our data further reveal that IL-10 secretion is characteristic of IgM+ naïve and memory B cells but suppressive activity is not restricted to IL-10: (i) the inhibitory effect of TNFR2+ switched memory B cells was comparable to that exerted by TNFR2+ IgM+ memory B cells although IL-10 secretion levels in the cocultures were lower; (ii) supernatants from TNFR2+ memory B cells failed to suppress T-cell proliferation. Based on our findings, we propose that formation of Breg is a specific characteristic of human memory B cells undergoing terminal differentiation. Our data further corroborate that TNFR2 represents a viable marker for identification of memory B cells with regulatory function.

Department of Clinical Immunology and Allergology St Anne's Faculty Hospital Masaryk University Brno Czech Republic

Division of Microbiology Paul Ehrlich Institut Langen Germany

Institute of Medical Microbiology Immunology and Parasitology University Hospital Bonn Bonn Germany

Zobrazit více v PubMed

Shen, P. and Fillatreau, S., Antibody-independent functions of B cells: a focus on cytokines. Nat. Rev. Immunol. 2015. 15: 441-451.

Candando, K. M., Lykken, J. M. and Tedder, T. F., B10 cell regulation of health and disease. Immunol. Rev. 2014. 259: 259-272.

Han, J., Sun, L., Fan, X., Wang, Z., Cheng, Y., Zhu, J. and Jin, T., Role of regulatory B cells in neuroimmunologic disorders. J. Neurosci. Res. 2016. 94: 693-701.

Vlková, M., Fronková, E., Kanderová, V., Janda, A., Ruzicková, S., Litzman, J., Sedivá, A. et al., Characterization of lymphocyte subsets in patients with common variable immunodeficiency reveals subsets of naive human B cells marked by CD24 expression. J. Immunol. 2010. 185: 6431-6438.

Capolunghi, F., Cascioli, S., Giorda, E., Rosado, M. M., Plebani, A., Auriti, C., Seganti, G. et al., CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J.I. 2008. 180: 800-808.

Bekeredjian-Ding, I., Doster, A., Schiller, M., Heyder, P., Lorenz, H.-M., Schraven, B., Bommhardt, U. et al., TLR9-Activating DNA up-regulates ZAP70 via sustained PKB induction in IgM+ B cells.J. Immunol. 2008. 181: 8267-8277.

Seifert, M., Przekopowitz, M., Taudien, S., Lollies, A., Ronge, V., Drees, B., Lindemann, M. et al., Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions. Proc. Natl. Acad. Sci. U.S.A. 2015. 112: E546-55.

Rosser, E. C. and Mauri, C., Regulatory B cells: origin, phenotype, and function. Immunity. 2015. 42: 607-612.

Mauri, C. and Bosma, A., Immune regulatory function of B cells. Annu. Rev. Immunol. 2012. 30: 221-241.

Gray, D. and Gray, M., What are regulatory B cells? Eur. J. Immunol. 2010. 40: 2677-2679.

Lykken, J. M., Candando, K. M. and Tedder, T. F., Regulatory B10 cell development and function. Int. Immunol. 2015. 27: 471-477.

Duddy, M., Niino, M., Adatia, F., Hebert, S., Freedman, M., Atkins, H., Kim, H. J. et al., , Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 2007. 178: 6092-6099.

Valizadeh, A., Sanaei, R., Rezaei, N., Azizi, G., Fekrvand, S., Aghamohammadi, A. and Yazdani, R., Potential role of regulatory B cells in immunological diseases. Immunol. Lett. 2019. 215: 48-59.

Sarvaria, A., Madrigal, J. A. and Saudemont, A., B cell regulation in cancer and anti-tumor immunity. Cell. Mol. Immunol. 2017. 14: 662-674.

Sedger, L. M. and McDermott, M. F., TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants-past, present and future. Cytokine Growth Factor Rev. 2014. 25: 453-472.

Rauert, H., Stühmer, T., Bargou, R., Wajant, H. and Siegmund, D., TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms. Cell Death Dis. 2011. 2: e194.

Wajant, H., Pfizenmaier, K. and Scheurich, P., Tumor necrosis factor signaling. Cell Death Differ. 2003. 10: 45-65.

Horiuchi, T., Mitoma, H., Harashima, S.-i., Tsukamoto, H. and Shimoda, T., Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford). 2010. 49: 1215-1228.

Grell, M., Douni, E., Wajant, H., Löhden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., et al.,, The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 1998. 83: 793-802.

Grell, M., Wajant, H., Zimmermann, G. and Scheurich, P., The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc. Natl. Acad. Sci. U.S.A. 1998. 95: 570-575.

Miller, P. G., Bonn, M. B. and McKarns, S. C., Transmembrane TNF-TNFR2 impairs Th17 differentiation by promoting Il2 expression. J. Immunol. 2015. 195: 2633-2647.

Rossol, M., Meusch, U., Pierer, M., Kaltenhauser, S., Hantzschel, H., Hauschildt, S. and Wagner, U., Interaction between transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells. J. Immunol. 2007. 179: 4239-4248.

Pallai, A., Kiss, B., Vereb, G., Armaka, M., Kollias, G., Szekanecz, Z. and Szondy, Z., Transmembrane TNF-alpha reverse signaling inhibits lipopolysaccharide-induced proinflammatory cytokine formation in macrophages by inducing TGF-beta: therapeutic implications. J. Immunol. 2016. 196: 1146-1157.

Qu, Y., Zhao, G. and Li, H., Forward and reverse signaling mediated by transmembrane tumor necrosis factor-alpha and TNF receptor 2: potential roles in an immunosuppressive tumor microenvironment. Front. Immunol. 2017. 8: 1675.

Eissner, G., Kolch, W. and Scheurich, P., Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev. 2004. 15: 353-366.

Aspalter, R. M., Eibl, M. M. and Wolf, H. M., Regulation of TCR-mediated T cell activation by TNF-RII. J. Leukoc. Biol. 2003. 74: 572-582.

Chen, X. and Oppenheim, J. J., The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells. Immunology. 2011. 133: 426-433.

Maney, N. J., Reynolds, G., Krippner-Heidenreich, A. and Hilkens, C. M. U., Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. J. Immunol. 2014. 193: 4914-4923.

Wajant, H. and Siegmund, D., TNFR1 and TNFR2 in the control of the life and death balance of macrophages. Front. Cell Dev. Biol. 2019. 7: 91.

Morais, B. S., Teixeira, A. L., Maciel, J. F., Lima, A. A., Barbosa, I. G. and Sanches, M. D., Soluble tumor necrosis factor receptors as predictors of 1-year mortality and renal dysfunction after liver transplantation. Transpl. Immunol. 2016. 35: 29-33.

Josephs, S. F., Ichim, T. E., Prince, S. M., Kesari, S., Marincola, F. M., Escobedo, A. R. and Jafri, A., Unleashing endogenous TNF-alpha as a cancer immunotherapeutic. J. Transl. Med. 2018. 16: 242.

Moura, A. S., Carmo, R. A., Teixeira, A. L. and Rocha, M. O. d. C., Soluble inflammatory markers as predictors of hepatocellular damage and therapeutic response in chronic hepatitis C. Braz. J. Infect Dis. 2009. 13: 375-382.

Ticha, O., Moos, L., Wajant, H. and Bekeredjian-Ding, I., Expression of tumor necrosis factor receptor 2 characterizes TLR9-driven formation of interleukin-10-producing B cells. Front. Immunol. 2017. 8: 1951.

Bouaziz, J.-D., Calbo, S., Maho-Vaillant, M., Saussine, A., Bagot, M., Bensussan, A. and Musette, P., IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur. J. Immunol. 2010. 40: 2686-2691.

Gallego-Valle, J., Perez-Fernandez, V. A., Correa-Rocha, R. and Pion, M., Generation of human Breg-like phenotype with regulatory function in vitro with bacteria-derived oligodeoxynucleotides. Int. J. Mol. Sci. 2018. 19: 1737.

Vlkova, M., Ticha, O., Nechvatalova, J., Kalina, T., Litzman, J., Mauri, C. and Blair, P. A., Regulatory B cells in CVID patients fail to suppress multifunctional IFN-γ+ TNF-α+ CD4+ T cells differentiation. Clin. Immunol. 2015. 160: 292-300.

Barsotti, N. S., Almeida, R. R., Costa, P. R., Barros, M. T., Kalil, J. and Kokron, C. M., IL-10-producing regulatory B cells are decreased in patients with common variable immunodeficiency. PloS ONE. 2016. 11: e0151761.

Chen, X., Subleski, J. J., Hamano, R., Howard, O. M. Z., Wiltrout, R. H. and Oppenheim, J. J., Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood. Eur. J. Immunol. 2010. 40: 1099-1106.

Medler, J. and Wajant, H., Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target. Expert Opin. Ther. Targets. 2019. 23: 295-307.

Yang, S., Wang, J., Brand, D. D. and Zheng, S. G., Role of TNF-TNF receptor 2 signal in regulatory T cells and its therapeutic implications. Front. Immunol. 2018. 9: 784.

Lemoine, S., Morva, A., Youinou, P. and Jamin, C., Human T cells induce their own regulation through activation of B cells. J. Autoimmun. 2011. 36: 228-238.

Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R. and Mauri, C., CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010. 32: 129-140.

Achour, A., Simon, Q., Mohr, A., Séité, J.-F., Youinou, P., Bendaoud, B. and Ghedira, I. et al., Human regulatory B cells control the TFH cell response. J. Allergy Clin. Immunol. 2017. 140: 215-222.

Zhu, G., Liu, Y., Zhang, W., Huang, Y. and Li, K., CD27+TIM-1+ memory B cells promoted the development of Foxp3+ Tregs and were associated with better survival in acute respiratory distress syndrome. Immunol. Res. 2018. 66: 281-287.

Chen, Y., Li, C., Lu, Y., Zhuang, H., Gu, W., Liu, B., Liu, F. et al., IL-10-producing CD1dhiCD5+ regulatory B cells may play a critical role in modulating immune homeostasis in silicosis patients. Front. Immunol. 2017. 8: 110.

Iwata, Y., Matsushita, T., Horikawa, M., Dilillo, D. J., Yanaba, K., Venturi, G. M., Szabolcs, P. M. et al., Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011. 117: 530-541.

van de Veen, W., Stanic, B., Yaman, G., Wawrzyniak, M., Söllner, S., Akdis, D. G., Rückert, B. et al., IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J. Allergy Clin. Immunol. 2013. 131: 1204-1212.

Lighaam, L. C., Unger, P.-P. A., Vredevoogd, D. W., Verhoeven, D., Vermeulen, E., Turksma, A. W., Brinke, A. ten et al., In vitro-induced human IL-10(+) B cells do not show a subset-defining marker signature and plastically co-express IL-10 with pro-inflammatory cytokines. Front. Immunol. 2018. 9: 1913.

Hasan, M. M., Thompson-Snipes, L., Klintmalm, G., Demetris, A. J., O'Leary, J., Oh, S. and Joo, H., CD24hiCD38hi and CD24hiCD27+ human regulatory B cells display common and distinct functional characteristics. J. Immunol. 2019. 203: 2110-2120.

Bernasconi, N. L., Onai, N. and Lanzavecchia, A., A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood. 2003. 101: 4500-4504.

Vásquez, C., Franco, M. A. and Angel, J., Rapid proliferation and differentiation of a subset of circulating IgM memory B cells to a CpG/cytokine stimulus in vitro. PloS ONE. 2015. 10: e0139718.

Bekeredjian-Ding, I. and Jego, G., Toll-like receptors-sentries in the B-cell response. Immunology. 2009. 128: 311-323.

Lin, W., Cerny, D., Chua, E., Duan, K., Yi, J. T. J., Shadan, N. B., Lum, J. et al., Human regulatory B cells combine phenotypic and genetic hallmarks with a distinct differentiation fate. J.I. 2014. 193: 2258-2266.

Ray, A. and Dittel, B. N., Mechanisms of regulatory B cell function in autoimmune and inflammatory diseases beyond IL-10. J. Clin. Med. 2017. 6: 12.

Huang, A., Cheng, L., He, M., Nie, J., Wang, J. and Jiang, K., Interleukin-35 on B cell and T cell induction and regulation. J. Inflamm (Lond). 2017. 14: 16.

Mirlekar, B., Michaud, D., Lee, S. J., Kren, N. P., Harris, C., Greene, K., Goldman, E. C. et al., B cell-derived IL35 drives STAT3-dependent CD8+ T-cell exclusion in pancreatic cancer. Cancer Immunol. Res. 2020. 8: 292-308.